Abstract
Mycoplasma pneumoniae causes upper and lower respiratory-tract disease. In addition, extra-pulmonary diseases may occur at the same time as the pulmonary infection or soon after. These complications may involve neurological, dermatological, musculoskeletal, cardiovascular, gastrointestinal, renal and hematological systems, or more than one of these. Complications which are dermatological, musculoskeletal and gastrointestinal are seen most frequently (15-50%) but are not as serious as nervous, cardiac and blood disorders. The mechanism behind the development of these complications is largely immunological. The extent to which autoimmune phenomena are responsible varies, evidence for this being greatest for hematological disorders and least for gastrointestinal ones.
Keywords: Mycoplasma pneumoniae, infection, autoimmunity, immunopathology.
Current Pediatric Reviews
Title:Immunopathological Aspects of Mycoplasma pneumoniae Infection
Volume: 9 Issue: 4
Author(s): David Taylor-Robinson
Affiliation:
Keywords: Mycoplasma pneumoniae, infection, autoimmunity, immunopathology.
Abstract: Mycoplasma pneumoniae causes upper and lower respiratory-tract disease. In addition, extra-pulmonary diseases may occur at the same time as the pulmonary infection or soon after. These complications may involve neurological, dermatological, musculoskeletal, cardiovascular, gastrointestinal, renal and hematological systems, or more than one of these. Complications which are dermatological, musculoskeletal and gastrointestinal are seen most frequently (15-50%) but are not as serious as nervous, cardiac and blood disorders. The mechanism behind the development of these complications is largely immunological. The extent to which autoimmune phenomena are responsible varies, evidence for this being greatest for hematological disorders and least for gastrointestinal ones.
Export Options
About this article
Cite this article as:
Taylor-Robinson David, Immunopathological Aspects of Mycoplasma pneumoniae Infection, Current Pediatric Reviews 2013; 9 (4) . https://dx.doi.org/10.2174/157339630904131223104117
DOI https://dx.doi.org/10.2174/157339630904131223104117 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Adult Stem Cells and Skeletal Muscle Regeneration
Current Gene Therapy Ultrasound Techniques for Drug Delivery in Cardiovascular Medicine
Current Drug Discovery Technologies The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
Current Cardiology Reviews Cellular Therapy for Myocardial Repair
Current Cardiology Reviews Multidrug Resistance Associated Proteins as Determining Factors of Pharmacokinetics and Pharmacodynamics of Drugs
Current Drug Metabolism Diamidine Activity Against Trypanosomes: The State of the Art
Current Molecular Pharmacology Stem Cells and Cardiac Disease: Where are We Going?
Current Stem Cell Research & Therapy Reviewing the Cardiovascular Complications of HIV Infection After the Introduction of Highly Active Antiretroviral Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Association between Serum Vitamin D Level and Echocardiographic Abnormalities in Patients with Thalassemia Major
Cardiovascular & Hematological Disorders-Drug Targets Cardiovascular Effects of Glucagon-Like Peptide 1
Mini-Reviews in Medicinal Chemistry RAGE: A Multi-Ligand Receptor Unveiling Novel Insights in Health and Disease
Current Medicinal Chemistry Microvascular Function/Dysfunction Downstream a Coronary Stenosis
Current Pharmaceutical Design Reactive Oxygen Species in Myocardial Reperfusion Injury: From Physiopathology to Therapeutic Approaches
Current Pharmaceutical Biotechnology Chronic Heart Failure- Potential for Pharmacological Intervention
Current Medicinal Chemistry - Cardiovascular & Hematological Agents H19: A Vital Long Noncoding RNA in the Treatment of Diabetes and Diabetic Complications
Current Pharmaceutical Design Targeting the Arrhythmogenic Substrate in Atrial Fibrillation: Focus on Structural Remodeling
Current Drug Targets Supplementation of Creatine and Ribose Prevents Apoptosis and Right Ventricle Hypertrophy in Hypoxic Hearts
Current Pharmaceutical Design Phenotypic Characterization of a Family With An In-frame Deletion in the DMD Gene and Variable Penetrance
Current Gene Therapy Cross Talk between the Cardiovascular and Nervous Systems:Neurotrophic Effects of Vascular Endothelial Growth Factor (VEGF) and Angiogenic Effects of Nerve Growth Factor (NGF)-Implications in Drug Development
Current Pharmaceutical Design Amniotic Fluid Embolism: Moving Diagnosis Through the Time. From the Mechanical Pulmonary Vascular Occlusion Until An Immuno - Inflammatory Pathogenesis?
Current Pharmaceutical Biotechnology